Wall Street Journal |
EpiPen Maker Mylan Tied Executive Pay to Aggressive Profit Targets
Wall Street Journal The drugmaker at the center of a firestorm over hefty price increases on the lifesaving EpiPen put a special incentive plan in place more than two years ago that rewards executives if they hit aggressive profit targets. In early 2014, the board of ... EpiPen prices and other problems Mylan's EpiPen Price-Gouging is Unethical You Too Can Experience The Joy Of Price Gouging Sick People In 'EpiPen Tycoon' |
from Top Stories - Google News http://ift.tt/2bFyHIB
0 comments:
Post a Comment